About us jenerasite February 6, 2020

About Us

BRAND DESCRIPTION

Overview

Jennera HA Dermal Filler

Jennera Dermal Fillers are designed to preserve tissue hydration, stimulate your own hyaluronic acid production, soften the appearance of lines & wrinkles and enhance your own features with natural looking outcomes.

Once administered, Jennera Dermal Filler smoothes the wrinkles from within, supports cutaneous tissues according to their needs and gives back lost elasticity.

Pharmaceutical Grade Hyaluronic Acid

Jennera Derma Fillers (Manufactured by Reanzen Factory) strictly use only Pharmaceutical Grade HA produced in the EU.

  1. Stable molecular weight
    It contributes to the realization of predictable efficacy and stability of final products.
  2. High Quality HA
    In the manufacturing process, raw HA is less physically and chemically modified, contributing to the realization of consistent safety of the final product.
  3. Low Endotoxin and Protein Load
    Contributes to minimizing the possibility of inflammation and allergy reaction caused by raw materials in final products.
BRAND DESCRIPTION

Advantage

HEXAGONAL BLOCK CROSSLINKING TECHNOLOGY

lONG - LASTING

JENNERA features a precise porous microparticle structure with unique characteristics, including a compact hexagonal formation linked through HBCT (Hexagonal Block Crosslinking Technology).

This technology was designed to slow the filler’s degradation rate in the body, thereby enhancing its longevity.

JENNERA is a top-quality filler that excels in wrinkle improvement and volume recovery, maintaining its viscoelasticity for a longer duration compared to other products that experience a decline in viscoelasticity post-production.
BRAND DESCRIPTION

Specificaion

SOFT

Gel type: Monophasic
Crosslinked HA: 24 mg/ ml
Lidocaine HCI: 3 mg/ ml
Extrusion Force: 10 ~ 25N
pH: 6.8 ~ 7.5
Viscoelasticity: 60 ~ 120pa
Needle Size : 30G * 2 Needles
Duration : 8 ~ 12 months
Storage: 2 ~ 25°C
Cross-linking agent: BDDE (1,4-Butannedio Diglycidyl Ether)
Injection depth: Dermis
Packaging: 1 x 1.1 ml
Shelf Life: 24 months

MID

Gel type: Monophasic
Crosslinked HA: 24 mg/ ml
Lidocaine HCI: 3 mg/ ml
Extrusion Force: 10 ~ 25N
pH: 6.8 ~ 7.5
Viscoelasticity: 215 ~ 255pa
Needle Size : 27G * 2 Needles
Duration : 12 ~ 18 months
Storage: 2 ~ 25°C
Cross-linking agent: BDDE (1,4-Butannedio Diglycidyl Ether)
Injection depth: Subcutaneous
Packaging: 1 x 1.1 ml
Shelf Life: 24 months

ULTRA

Gel type: Monophasic
Crosslinked HA: 24 mg/ ml
Lidocaine HCI: 3 mg/ ml
Extrusion Force: 10 ~ 25N
pH: 6.8 ~ 7.5
Viscoelasticity: 260 ~ 300pa
Needle Size : 25G * 2 Needles
Duration : 12 ~ 18 months
Storage: 2 ~ 25°C
Cross-linking agent: BDDE (1,4-Butannedio Diglycidyl Ether)
Injection depth: Deep Subcutaneous
Packaging: 1 x 1.1 ml
Shelf Life: 24 months
BRAND DESCRIPTION

Injection Technology

HIGH COMFORT OF THE TREATMENT

Thanks to the presence of 0.3% lidocaine and thin-walled needles, pain is significantly reduced, increasing patient comfort. The injection is practically painless and spreading into the tissues is not felt.

COMFORT OF USE AND SMOOTHNESS OF INJECTION

The product’s exceptional elasticity and excellent rheological properties allow for an easy and precise administration. In addition, the ergonomically designed syringe handle enables even distribution of pressure during injection, guaranteeing precise and even administration of the product.
PROTOCOL

Injection Map

BEFORE & AFTER

Treatment Example

Glabellar lines
improvement
Nasolabial folds
improvement
Nasolabial folds
improvement
Lip enlargement
improvement
PROTCOL

Certificates

METICULOUS MANUFACTURING

JENNERA is produced in the best quality facility
– New manufacturing and analysis equipment
– Strict quality control and assurance system (GMP, ISO13485)
– Top-of-the-line materials used from manufacturing to packaging